t13176 bay 293 targetmol (TargetMol)
93
Structured Review
TargetMol
t13176 bay 293 targetmol
T13176 Bay 293 Targetmol, supplied by TargetMol, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/t13176+bay+293+targetmol/TNO155/pm40812300-302-87-89
Average 93 stars, based on 1 article reviews
T13176 Bay 293 Targetmol, supplied by TargetMol, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/t13176+bay+293+targetmol/TNO155/pm40812300-302-87-89
Average 93 stars, based on 1 article reviews
t13176 bay 293 targetmol - by Bioz Stars,
2026-09
93/100 stars
Images
Related Articles
Sequencing:Article Title: A pancreatic cancer organoid biobank links multi-omics signatures to therapeutic response and clinical evaluation of statin combination therapy. Article Snippet: REAGENT or RESOURCE SOURCE IDENTIFIER KU-55933 TargetMol Cat# T2685 Ralimetinib dimesylate TargetMol Cat# T6047 SU5402 TargetMol Cat# T6996 Axitinib TargetMol Cat# T1452 Letrozole TargetMol Cat# T1590 Irbinitinib(Tucatinib) TargetMol Cat# T2364 Erdafitinib TargetMol Cat# T3726 Trametinib TargetMol Cat# T2125 Dabrafenib TargetMol Cat# T1903 Wortmannin TargetMol Cat# T6283 Lovastatin TargetMol Cat# T1207 Fulvestrant TargetMol Cat# T2146 Nilutamide TargetMol Cat# T0272 Bicalutamide TargetMol Cat# T0380 Cytarabine TargetMol Cat# T1272 Pomalidomide TargetMol Cat# T2384 Lenalidomide TargetMol Cat# T1642 Pitavastatin calcium TargetMol Cat# T2534 Rapamycin TargetMol Cat# T1537 RHPS4 TargetMol Cat# T6967 BIBR 1532 TargetMol Cat# T2380 10058-F4 TargetMol Cat# T3048 Danusertib TargetMol Cat# T2094 Pazopanib TargetMol Cat# T0097L Sunitinib TargetMol Cat# T0374L Erlotinib TargetMol Cat# T0373 Ilorasertib TargetMol Cat# TQ0059 Pralsetinib TargetMol Cat# TQ0277 Tipifarnib TargetMol Cat# T6271 Defactinib TargetMol Cat# T1996 GSK2256098 TargetMol Cat# T2281 Selumetinib TargetMol Cat# T6218 Vemurafenib TargetMol Cat# T2382 Encorafenib TargetMol Cat# T6487 LY294002 TargetMol Cat# T2008 Alpelisib TargetMol Cat# T1921 Capivasertib TargetMol Cat# T1920 Everolimus TargetMol Cat# T1784 BLU2864 TargetMol Cat# T60170 Vismodegib TargetMol Cat# T2590 Erismodegib(Sonidegib) TargetMol Cat# T1926 Olaparib TargetMol Cat# T3015 Niraparib TargetMol Cat# T3231 Mirdametinib TargetMol Cat# T6189 10074-G5 TargetMol Cat# T3686 Poziotinib TargetMol Cat# T2630 Regorafenib TargetMol Cat# T1792 Lapatinib TargetMol Cat# T0078 Foretinib TargetMol Cat# T3113 (Continued on next page) Cell Stem Cell 32, 1369–1389.e1–e14, September 4, 2025 e2 .. REAGENT or RESOURCE SOURCE IDENTIFIER Cobimetinib TargetMol Cat# T3623 Sorafenib TargetMol Cat# T0093L Dinaciclib(CDK inhibitor) TargetMol Cat# T1912 Tunicamycin TargetMol Cat# T13229 Afatinib TargetMol Cat# T21312 AZD7762 TargetMol Cat# T6093 capecitabine Selleck chemicals Cat# S1156 cisplatin Selleck chemicals Cat# S1166 Doxorubicin Selleck chemicals Cat# E2516 5-FU Selleck chemicals Cat# S1209 Oxaliplatin Selleck chemicals Cat# S1224 Irinotecan Selleck chemicals Cat# S1198 Gemcitabine Selleck chemicals Cat# S1714 Paclitaxel Selleck chemicals Cat# S1150 R428 Selleck chemicals Cat# S2841 BB-94 Selleck chemicals Cat# S7155 Sotorasib TargetMol Cat# T8684 TNO115 TargetMol Cat# RNA Sequencing:Article Title: A pancreatic cancer organoid biobank links multi-omics signatures to therapeutic response and clinical evaluation of statin combination therapy. Article Snippet: REAGENT or RESOURCE SOURCE IDENTIFIER KU-55933 TargetMol Cat# T2685 Ralimetinib dimesylate TargetMol Cat# T6047 SU5402 TargetMol Cat# T6996 Axitinib TargetMol Cat# T1452 Letrozole TargetMol Cat# T1590 Irbinitinib(Tucatinib) TargetMol Cat# T2364 Erdafitinib TargetMol Cat# T3726 Trametinib TargetMol Cat# T2125 Dabrafenib TargetMol Cat# T1903 Wortmannin TargetMol Cat# T6283 Lovastatin TargetMol Cat# T1207 Fulvestrant TargetMol Cat# T2146 Nilutamide TargetMol Cat# T0272 Bicalutamide TargetMol Cat# T0380 Cytarabine TargetMol Cat# T1272 Pomalidomide TargetMol Cat# T2384 Lenalidomide TargetMol Cat# T1642 Pitavastatin calcium TargetMol Cat# T2534 Rapamycin TargetMol Cat# T1537 RHPS4 TargetMol Cat# T6967 BIBR 1532 TargetMol Cat# T2380 10058-F4 TargetMol Cat# T3048 Danusertib TargetMol Cat# T2094 Pazopanib TargetMol Cat# T0097L Sunitinib TargetMol Cat# T0374L Erlotinib TargetMol Cat# T0373 Ilorasertib TargetMol Cat# TQ0059 Pralsetinib TargetMol Cat# TQ0277 Tipifarnib TargetMol Cat# T6271 Defactinib TargetMol Cat# T1996 GSK2256098 TargetMol Cat# T2281 Selumetinib TargetMol Cat# T6218 Vemurafenib TargetMol Cat# T2382 Encorafenib TargetMol Cat# T6487 LY294002 TargetMol Cat# T2008 Alpelisib TargetMol Cat# T1921 Capivasertib TargetMol Cat# T1920 Everolimus TargetMol Cat# T1784 BLU2864 TargetMol Cat# T60170 Vismodegib TargetMol Cat# T2590 Erismodegib(Sonidegib) TargetMol Cat# T1926 Olaparib TargetMol Cat# T3015 Niraparib TargetMol Cat# T3231 Mirdametinib TargetMol Cat# T6189 10074-G5 TargetMol Cat# T3686 Poziotinib TargetMol Cat# T2630 Regorafenib TargetMol Cat# T1792 Lapatinib TargetMol Cat# T0078 Foretinib TargetMol Cat# T3113 (Continued on next page) Cell Stem Cell 32, 1369–1389.e1–e14, September 4, 2025 e2 .. REAGENT or RESOURCE SOURCE IDENTIFIER Cobimetinib TargetMol Cat# T3623 Sorafenib TargetMol Cat# T0093L Dinaciclib(CDK inhibitor) TargetMol Cat# T1912 Tunicamycin TargetMol Cat# T13229 Afatinib TargetMol Cat# T21312 AZD7762 TargetMol Cat# T6093 capecitabine Selleck chemicals Cat# S1156 cisplatin Selleck chemicals Cat# S1166 Doxorubicin Selleck chemicals Cat# E2516 5-FU Selleck chemicals Cat# S1209 Oxaliplatin Selleck chemicals Cat# S1224 Irinotecan Selleck chemicals Cat# S1198 Gemcitabine Selleck chemicals Cat# S1714 Paclitaxel Selleck chemicals Cat# S1150 R428 Selleck chemicals Cat# S2841 BB-94 Selleck chemicals Cat# S7155 Sotorasib TargetMol Cat# T8684 TNO115 TargetMol Cat# |